Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.62127 | 60 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.56105 | 59 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.57048 | 60 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.36234 | 56 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.46456 | 58 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.66712 | 60 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.60816 | 59 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.53994 | 59 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.50134 | 58 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.55052 | 59 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.54401 | 59 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.53794 | 60 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.55664 | 59 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.55133 | 59 |